TMJ Disorder Clinical Trial
Official title:
Treatment of Temporomandibular Joint Internal Derangement Using MESNA Injection
The pathogenesis of temporomandibular disorders focusing on the biochemistry of the synovial fluid in various stages of temporomandibular joint disease. The role of inflammation has been investigated and proposed as an underlying mechanism of pain and dysfunction of temporomandibular joint. MESNA (sodium 2-mercaptoethanesulfonate) was approved several years ago and marketed in several formulations as a mucolytic agent in the respiratory field, since it breaks the disulfide bonds between polypeptide chains of mucus. The tissue distribution of MESNA is negligible, and the elimination of the substance is rapidly and completely achieved by kidney
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
| Completed |
NCT06103110 -
Effect of Order and Conjugation of Different Photobiomodulation Therapies and Anterior Repositioning Appliance in Management of TMD Cases
|
N/A | |
| Completed |
NCT04561037 -
Pulsed Electromagnetic Field Therapy for TMJ Dysfunction After Facial Penetrating Injury
|
N/A | |
| Completed |
NCT04951908 -
Correlation Between Types of Lateral Pterygoid Muscle Attachment and Internal Derangement of the Temporomandibular Joint
|
||
| Completed |
NCT05712655 -
Masticatory Muscles Electromyography in Post-pubertal Females With Forward Head Posture and Temporomandibular Disorders
|
||
| Recruiting |
NCT04543981 -
Prevalence of the Signs and Symptoms of TMD in Adolescents
|
||
| Not yet recruiting |
NCT05320770 -
Role of Ultrasonography in Assessment of Tempromanbular Joint Disorders
|
N/A | |
| Completed |
NCT04298554 -
Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region
|
N/A |